Osteoarthritis (OA) Pain Therapeutics - Pipeline

Assessment and Market Forecasts to 2019

On 30thDecember 2014

Summary
The industry analysis specialist, has released its new report, Osteoarthritis (OA) Pain
Therapeutics - Pipeline Assessment and Market Forecasts to 2019. The report is an essential
source of information and analysis on the global Osteoarthritis Pain Therapeutics market. The
report identifies the key trends shaping and driving the global Osteoarthritis Pain Therapeutics
market. The report also provides insights on the prevalent competitive landscape and the
emerging players expected to significantly alter the market positioning of the current market
leaders. Most importantly, the report provides valuable insights on the pipeline products within
the global Osteoarthritis Pain Therapeutics sector. This report is built using data and
information sourced from proprietary databases, primary and secondary research and in-house
analysis by GlobalDatas team of industry experts.

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-osteoarthritis-oa-pain-therapeutics-pipeline-assessment-and-marketforecasts-135228

Scope
The report provides information on the key drivers and challenges of the Osteoarthritis Pain
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Osteoarthritis
Pain Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Osteoarthritis Pain
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Osteoarthritis Pain Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Osteoarthritis Pain
Therapeutics market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global
Osteoarthritis Pain Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Osteoarthritis Pain Therapeutics
market in future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
partnerships.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Whats the next big thing in the global Osteoarthritis Pain Therapeutics market landscape?
Identify, understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com

Table of Content
2 Osteoarthritis Pain Therapeutics - Introduction
2.1 Disease Overview
2.1.1 Classification of Osteoarthritis
2.1.2 Types of Osteoarthritis
2.1.3 Osteoarthritis Pain
2.2 Epidemiology
2.2.1 Prevalence
2.3 Quality of Life
2.4 Etiology
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.5 Signs and Symptoms

2.6 Diagnosis
2.6.1 Physical Examination
2.6.2 Radiological Examination
2.6.3 Laboratory Test
2.7 Pathophysiology
2.7.1 Progression of the Disease
2.8 Treatment and Management Options
2.8.1 Pharmacological treatment
2.9 Referral Pathway
2.10 GlobalData Pipeline Report Guidance
3 Osteoarthritis Pain Therapeutics - Market Characterization
3.1 Overview
3.2 Osteoarthritis Pain Therapeutics Market Size (2006-2011) Global
3.3 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) Global
3.4 Osteoarthritis Pain Therapeutics Market Size (2006-2011) The US
3.5 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) The US
3.6 Osteoarthritis Pain Therapeutics Market Size (2006-2011) France
3.7 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) France
3.8 Osteoarthritis Pain Therapeutics Market Size (2006-2011) Germany
3.9 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) Germany
3.10 Osteoarthritis Pain Therapeutics Market Size (2006-2011) Italy
3.11 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) Italy
3.12 Osteoarthritis Pain Therapeutics Market Size (2006-2011) Spain
3.13 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) Spain
3.14 Osteoarthritis Pain Therapeutics Market Size (2006-2011) The UK
3.15 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) The UK
3.16 Osteoarthritis Pain Therapeutics Market Size (2006-2011) Japan
3.17 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) Japan
3.18 Drivers and Barriers for the Osteoarthritis Pain Therapeutics Market
3.18.1 Drivers for the Osteoarthritis Pain Therapeutics Market
3.18.2 Barriers for the Osteoarthritis Pain Therapeutics Market
3.19 Opportunity and Unmet Need Analysis
3.20 Key Takeaway
4 Osteoarthritis Pain Therapeutics - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profiles for the Major Marketed Products in the Osteoarthritis Pain Therapeutics
Market
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

4.3.1 Celebrex (celecoxib)

4.3.2 Voltaren Gel (diclofenac sodium)
4.3.3 Hyalgan (sodium hyaluronate)
4.3.4 Cymbalta (duloxetine)
4.3.5 Synvisc (hylan G-F 20)
4.4 Key Takeaway
5 Osteoarthritis Pain Therapeutics - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Osteoarthritis Pain Therapeutics Pipeline Pipeline by Phases of Development
5.3.1 Osteoarthritis Pain Therapeutics Regulatory Filed Products
5.3.2 Osteoarthritis Pain Therapeutics Phase III Pipeline
5.3.3 Osteoarthritis Pain Therapeutics Phase II/III Pipeline
5.3.4 Osteoarthritis Pain Therapeutics Phase II Pipeline
5.3.5 Osteoarthritis Pain Therapeutics Phase I/II Pipeline
5.3.6 Osteoarthritis Pain Therapeutics Phase I Pipeline
5.3.7 Osteoarthritis Pain Market Discovery and Pre-Clinical Pipeline
5.3.8 Technology Trends Analytic Framework
5.4 Osteoarthritis Pain Therapeutics Market Pipeline by Mechanism of Action
5.5 Molecule Profile for Promising Drugs Under Development
5.5.1 2 PX
5.5.2 Civanex
5.5.3 BEMA
5.5.4 CEP-33237
5.6 Key Takeaway
6 Osteoarthritis Pain Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Region/Country (the US, EU5 and Japan)
6.2 Clinical Trials by Phase
6.3 Clinical Trials by Trial Status
6.4 Prominent Sponsors
6.5 Top Companies Participating in OA Pain Therapeutics Clinical Trials
7 Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Osteoarthritis Pain Therapeutics: Implications for Future Market Competition
8 Osteoarthritis Pain Therapeutics - Future Players
8.1 Introduction
8.2 Company Profiles
8.2.1 Winston Pharmaceuticals, Inc.
8.2.2 Teva Pharmaceuticals
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

8.2.3 Pfizer, Inc.

8.2.4 SantoSolvo AS
8.2.5 BioDelivery Sciences International, Inc.
8.2.6 Savient Pharmaceuticals, Inc.
8.2.7 Eli Lilly and Company
8.2.8 Horizon Pharma
8.2.9 Boehringer Ingelheim
9 Osteoarthritis Pain Therapeutics - Licensing and Partnership Deals
10 Osteoarthritis Pain Therapeutics - Appendix
10.1 Market Definitions
10.2 Abbreviations
10.3 Bibliography
10.4 Methodology
10.4.1 Coverage
10.4.2 Secondary Research
10.4.3 Forecasting
10.4.4 Primary Research
10.4.5 Expert Panel Validation
10.5 Contact Us
10.6 Disclaimer

List Of Tables
Table 1: Prevalence rates of Osteoarthritis Pain by Country/Region
Table 2: Prevalence Pool of Osteoarthritis Pain Patients in Seven Major Markets
Table 3: Clinical Features of Osteoarthritis Pain
Table 4: Classification Criteria for Osteoarthritis Pain
Table 5: Treatment Options for Osteoarthritis Pain
Table 6: Osteoarthritis Pain Therapeutics Market, Global, Revenue ($m), 20062011
Table 7: Osteoarthritis Pain Therapeutics Market, Global, Forecast ($m), 20112019
Table 8: Osteoarthritis Pain Therapeutics Market, The US, Revenue ($m), 20062011
Table 9: Osteoarthritis Pain Therapeutics Market, The US, Forecast ($m), 20112019
Table 10: Osteoarthritis Pain Therapeutics Market, France, Revenue ($m), 20062011
Table 11: Osteoarthritis Pain Therapeutics Market, France, Forecast ($m), 20112019
Table 12: Osteoarthritis Pain Therapeutics Market, Germany, Revenue ($m), 20062011
Table 13: Osteoarthritis Pain Therapeutics Market, Germany, Forecast ($m), 20112019
Table 14: Osteoarthritis Pain Therapeutics Market, Italy, Revenue ($m), 20062011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Table 15: Osteoarthritis Pain Therapeutics Market, Italy, Forecast ($m), 20112019
Table 16: Osteoarthritis Pain Therapeutics Market, Spain, Revenue ($m), 20062011
Table 17: Osteoarthritis Pain Therapeutics Market, Spain, Forecast ($m), 20112019
Table 18: Osteoarthritis Pain Therapeutics Market, The UK, Revenue ($m), 20062011
Table 19: Osteoarthritis Pain Therapeutics Market, The UK, Forecasts ($m), 20112019
Table 20: Osteoarthritis Pain Therapeutics Market, Japan, Revenue ($m), 20062011
Table 21: Osteoarthritis Pain Therapeutics Market, Japan, Forecasts ($m), 20112019
Table 22: Primary Efficacy Results for Synvisc: WOMAC Pain Score
Table 23: Adverse Events Associated with Synvisc
Table 24: Osteoarthritis Pain Therapeutics Regulatory Filed Products, 2012
Table 25: Osteoarthritis Pain Therapeutics Phase III Pipeline, 2012
Table 26: Osteoarthritis Pain Therapeutics Phase II/III Pipeline, 2012
Table 27: Osteoarthritis Pain Therapeutics Phase II Pipeline, 2012
Table 28: Osteoarthritis Pain Therapeutics Phase I/II Pipeline, 2012
Table 29: Osteoarthritis Pain Therapeutics Phase I Pipeline, 2012
Table 30: Osteoarthritis Pain Therapeutics Preclinical and Discovery Phase Pipeline, 2012
Table 31: Osteoarthritis Pain Therapeutics Clinical Trials by Country, 2012
Table 32: Osteoarthritis Pain Therapeutics Clinical Trials by Phase, 2012
Table 33: Osteoarthritis Pain Therapeutics Clinical Trials by Status, 2012
Table 34: Osteoarthritis Pain Therapeutics, Overall Sponsors, 2012
Table 35: Osteoarthritis Pain Therapeutics, Most Prominent Sponsors, 2012
Table 36: Osteoarthritis Pain Therapeutics - Top Companies Participating in Therapeutics
Clinical Trials, 2012
Table 37: Winston Pharmaceuticals, Inc. Osteoarthritis Pain Pipeline, 2012
Table 38: Osteoarthritis Pain Therapeutics, Cephalon Inc./Teva Pharmaceuticals, Osteoarthritis
Pain Therapeutics Pipeline, 2012
Table 39: Pfizer, Osteoarthritis Pain Pipeline, 2011
Table 40: Osteoarthritis Pain Therapeutics, SantoSolve Pain Management Pipeline, 2012
Table 41: Osteoarthritis Pain Therapeutics, BioDelivery Sciences Pain Management Pipeline,
2012
Table 42: Licensing and Partnership Deals, 2008-2011

List Of Figures
Figure 1: Differentiation between Normal Joint and Osteoarthritis Joint
Figure 2: Types of Osteoarthritis Pain
Figure 3: Knee Osteoarthritis
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 4: Osteoarthritis of Hand, Heberdens Nodes and Bouchards Nodes

Figure 5: Hip Osteoarthritis
Figure 6: Examples of Disc Problems which Lead to Spine Osteoarthritis
Figure 7: Joints and Bones of the Foot and Ankle
Figure 8: Factors Affecting Degeneration of Cartilage
Figure 9: Key Opinion Leader Insights, Diagnosis of Osteoarthritis Pain in the US and the UK.
Figure 10: Progression of Osteoarthritis Pain Disease
Figure 11: Key Opinion Leader Insights, Guidelines for Osteoarthritis Pain in the US and the UK
Figure 12: Summary of Treatment Options for Osteoarthritis Pain
Figure 13: Key Opinion Leader Insights, Treatment of Osteoarthritis Pain in the US and the UK
Figure 14: Key Opinion Leader Insights, Pharmacological Treatment for Osteoarthritis Pain in
the US and the UK
Figure 15: Management of Osteoarthritis of the Knee
Figure 16: Management of Osteoarthritis of the Hip
Figure 17: Referral Pathway for Osteoarthritis Pain
Figure 18: Key Opinion Leader Insights, Referral Pathway for Osteoarthritis Pain in the US and
the UK
Figure 19: Osteoarthritis Pain Therapeutics Market, Global, Revenue ($m), 20062011
Figure 20: Osteoarthritis Pain Therapeutics Market, Global, Forecast ($m), 20112019
Figure 21: Osteoarthritis Pain Therapeutics Market, The US, Revenue ($m), 20062011
Figure 22: Osteoarthritis Pain Therapeutics Market, The US, Forecast ($m), 20112019
Figure 23: Osteoarthritis Pain Therapeutics Market, France, Revenue ($m), 20062011
Figure 24: Osteoarthritis Pain Therapeutics Market, France, Forecast ($m), 20112019
Figure 25: Osteoarthritis Pain Therapeutics Market, Germany , Revenue ($m), 20062011
Figure 26: Osteoarthritis Pain Therapeutics Market, Germany, Forecast ($m), 20112019
Figure 27: Osteoarthritis Pain Therapeutics Market, Italy, Revenue ($m), 20062011
Figure 28: Osteoarthritis Pain Therapeutics Market, Italy, Forecast ($m), 20112019
Figure 29: Osteoarthritis Pain Therapeutics Market, Spain, Revenue ($m), 20062011
Figure 30: Osteoarthritis Pain Therapeutics Market, Spain, Forecast ($m), 20112019
Figure 31: Osteoarthritis Pain Therapeutics Market, The UK, Revenue ($m), 20062011
Figure 32: Osteoarthritis Pain Therapeutics Market, The UK, Forecast ($m), 20112019
Figure 33: Osteoarthritis Pain Therapeutics Market, Japan, Revenue ($m), 20062011
Figure 34: Osteoarthritis Pain Therapeutics Market, Japan, Forecast ($m), 20112019
Figure 35: Key Opinion Leader Insights, Current Unmet Need for Osteoarthritis Pain in the US
and the UK
Figure 36: Opportunity and Unmet Need in the Osteoarthritis Pain Therapeutics Market, 2011
Figure 37: Key Opinion Leader Insights, Limitations with the Currently Available Treatment
Options for Osteoarthritis Pain in the US and the UK
Figure 38: Osteoarthritis Pain Therapeutics Strategic Competitor Assessment, 2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 39: Key Opinion Leader Insights, Research for Future Treatment Options for
Osteoarthritis Pain in the US and the UK
Figure 40: Osteoarthritis Pain Therapeutics Pipeline by Phase of Development, 2012
Figure 41: Osteoarthritis Pain Therapeutics Technology Trends Analytics Framework, 2012
Figure 42: Osteoarthritis Pain Therapeutics Technology Trends Analytics Framework
Description, 2012
Figure 43: Osteoarthritis Pain Therapeutics Pipeline by Mechanism of Action, 2012
Figure 44: Key Opinion Leader Insights, Target Profile Testing for Osteoarthritis Pain in the US
and the UK
Figure 45: Osteoarthritis Pain Therapeutics Clinical Trials by Country, 2012
Figure 46: Osteoarthritis Pain Therapeutics Clinical Trials by Phase, 2012
Figure 47: Osteoarthritis Pain Therapeutics Clinical Trials by Status, 2012
Figure 48: Osteoarthritis Pain Therapeutics Overall Sponsors, 2012
Figure 49: Osteoarthritis Pain Therapeutics Prominent Sponsors, 2012
Figure 50: Osteoarthritis Pain Therapeutics Top Companies Participating in Therapeutics
Clinical Trials, 2012
Figure 51: Osteoarthritis Pain Therapeutics Market, Drivers and Barriers 2011
Figure 52: Implications for Future Market Competition in the Osteoarthritis Pain Market, 2011
Figure 53: Osteoarthritis Pain Therapeutics Market Pipeline by Company, 2012

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Related Reports:
Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019
Toxoplasmosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Skin and Skin Structure Infections (SSSI) Therapeutics - Pipeline Assessment and Market Forecasts to
2019
Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts
to 2019
Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Athletes Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019
Vaginitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Pompe Disease (GAA Deficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

To know more on Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment

and Market Forecasts to 2019
http://www.jsbmarketresearch.com/healthcare-medical/r-osteoarthritis-oapain-therapeutics-pipeline-assessment-and-market-forecasts-135228

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/